KDCCP donates $100,000 to the Pediatric Hematology/Oncology Fellowship Program at Doernbecher Children’s Hospital, July 24, 2017
Payton Williams Draws 2017 Mustang Raffle Winner!
OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemia Kymriah, first gene transfer therapy in the U.S., now available for children and young adults with ALL
Eneida Nemecek, M.D., M.S., M.B.A., (third from right) and the OHSU Doernbecher CAR-T cell therapy team. (OHSU)